Edition:
India

Cronos Group Inc (CRON.OQ)

CRON.OQ on NASDAQ Stock Exchange Global Market

7.41USD
1:30am IST
Change (% chg)

$0.08 (+1.09%)
Prev Close
$7.33
Open
$7.30
Day's High
$7.51
Day's Low
$7.18
Volume
389,040
Avg. Vol
--
52-wk High
$10.38
52-wk Low
$5.13

Summary

Name Age Since Current Position

Michael Gorenstein

2016 President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary

William Hilson

2016 Chief Financial Officer

Jason Adler

2016 Director

Ryan Roebuck

32 Director

James Rudyk

2018 Director

Alan Friedman

45 2016 Independent Director

Michael Krestell

2016 Independent Director

Biographies

Name Description

Michael Gorenstein

William Hilson

Mr. William Hilson is a Chief Financial Officer of the Company. Mr. Hilson is a certified public accountant (CPA) and has spent over 15 years as regional chief financial officer of two publicly listed multinational pharmaceutical companies: Merck KGaA and Serono SA. His experience includes financial operations, strategy, performance management, sales and marketing, clinical trial management, international tax, as well as debt and equity financing. Prior to joining Cronos Group, Mr. Hilson was also involved in a number of mergers and acquisitions and licensing deals in the pharmaceutical sector.

Jason Adler

Mr. Jason Adler is Director of the Company. He is the CEO and Managing Member of Alphabet Ventures, LLC, a captive investment vehicle operating in a wide range of domains including growth equity, established companies with growth perspective, and creative debt vehicles. Prior to Alphabet Ventures Jason was the founder and CEO of Alphabet Management, LLC, a New York based volatility fund, that focused on identifying mispriced assets across various industries, asset classes and geographies. Jason also founded Geronimo, LLC, an AMEX member broker dealer that made markets in equity options, and he began his career as a market maker at G&D Trading, an AMEX member market maker. Jason received his B.A. from the University of Rhode Island.

Ryan Roebuck

Mr. Ryan Roebuck is a Director of the Company. Mr. Roebuck currently serves as a partner of XDR Capital Group, a private investment firm located in Toronto where he specializes in investing in public and private event driven and special situations in North America. Mr. Roebuck serves as Director and Chairman of the audit committee of Epsilon Energy Ltd., a Toronto Stock Exchange listed company.

James Rudyk

Mr. James Rudyk is Director of the Company. He has appointed James Rudyk to its board of directors. Mr. Rudyk is currently the chief financial officer of Roots Corp., a position he has held since January, 2016. Mr. Rudyk is an experienced and proven financial executive with more than 25 years of financial and operational experience and a record of supporting ambitious growth plans. Prior to joining Roots, Mr. Rudyk served as the chief financial officer of Shred-It International Inc. from 2009 to 2015. While at Shred-It, he was instrumental in helping the company grow from approximately $200-million to more than $700-million in revenue, expanding to over 17 countries around the world. He also served as chief financial officer and chief operating officer of Canada Cartage Systems Ltd. from 2004 to 2009. Mr. Rudyk is currently a board member of National Diabetes Trust Corp. and serves on ist audit committee and its governance, nominations and compensation committee.

Alan Friedman

Mr. Alan Mark Friedman is Independent Director of the Company. Mr. Friedman is an attorney and has played an integral role in the establishment, acquisitions, financings and go-public transactions for many Canadian companies. He is co-founder and Director of TSX-V listed companies, Adira Energy Ltd. and Eco (Atlantic) Oil and Gas Ltd. He was also co-founder of Auryx Gold Corp. a TSX listed gold company sold to B2 Gold Corp for $150mm in 2012. He is also CEO of Rivonia Capital, a Canadian boutique finance and facilitation company specializing in public market transactions.

Michael Krestell